Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,439 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Engaging communities in therapeutics clinical research during pandemics: Experiences and lessons from the ACTIV COVID-19 therapeutics research initiative.
Wohl DA, Adam SJ, Gibbs KW, Moskowitz AL, Ortel TL, Singh U, Jilg N, Evering TH, Fischer WA 2nd, Taiwo BO, Daar ES, Lindsell CJ, Naggie S, Rothman RL, Dunsmore SE, McAdams MP, Vail J, Jayaweera D. Wohl DA, et al. Among authors: fischer wa 2nd. J Clin Transl Sci. 2024 Oct 15;8(1):e156. doi: 10.1017/cts.2024.561. eCollection 2024. J Clin Transl Sci. 2024. PMID: 39540112 Free PMC article. Review.
ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic.
Keshtkar-Jahromi M, Anstrom KJ, Barkauskas C, Brown SM, Daar ES, Fischer W, Gibbs KW, Higgs ES, Hughes MD, Jagannathan P, LaVange L, Lindsell CJ, Nayak SU, Paredes R, Parmar M, Peltan ID, Proschan M, Shotwell MS, Vock DM, Yokum T, Adam SJ. Keshtkar-Jahromi M, et al. Among authors: fischer w. J Clin Transl Sci. 2024 Oct 15;8(1):e151. doi: 10.1017/cts.2024.1. eCollection 2024. J Clin Transl Sci. 2024. PMID: 39478775 Free PMC article. Review.
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.
Evering TH, Moser C, Jilg N, Ritz J, Wohl DA, Li JZ, Margolis D, Javan AC, Eron JJ, Currier JS, Daar ES, Smith DM, Hughes MD, Chew KW; ACTIV-2/A5401 Study Team. Evering TH, et al. EClinicalMedicine. 2024 Aug 16;75:102787. doi: 10.1016/j.eclinm.2024.102787. eCollection 2024 Sep. EClinicalMedicine. 2024. PMID: 39252866 Free PMC article.
Annotation-free prediction of microbial dioxygen utilization.
Flamholz AI, Goldford JE, Richter PA, Larsson EM, Jinich A, Fischer WW, Newman DK. Flamholz AI, et al. Among authors: fischer ww. mSystems. 2024 Oct 22;9(10):e0076324. doi: 10.1128/msystems.00763-24. Epub 2024 Sep 4. mSystems. 2024. PMID: 39230322 Free PMC article.
Health and economic impacts of Lassa vaccination campaigns in West Africa.
Smith DRM, Turner J, Fahr P, Attfield LA, Bessell PR, Donnelly CA, Gibb R, Jones KE, Redding DW, Asogun D, Ayodeji OO, Azuogu BN, Fischer WA 2nd, Jan K, Olayinka AT, Wohl DA, Torkelson AA, Dinkel KA, Nixon EJ, Pouwels KB, Hollingsworth TD. Smith DRM, et al. Among authors: fischer wa 2nd. Nat Med. 2024 Aug 28. doi: 10.1038/s41591-024-03232-y. Online ahead of print. Nat Med. 2024. PMID: 39198710
Host response to influenza infections in human blood: association of influenza severity with host genetics and transcriptomic response.
Schughart K, Smith AM, Tsalik EL, Threlkeld SC, Sellers S, Fischer WA 2nd, Schreiber J, Lücke E, Cornberg M, Debarry J, Woods CW, McClain MT, Heise M. Schughart K, et al. Among authors: fischer wa 2nd. Front Immunol. 2024 Aug 13;15:1385362. doi: 10.3389/fimmu.2024.1385362. eCollection 2024. Front Immunol. 2024. PMID: 39192977 Free PMC article.
1,439 results